Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Weber

Showing results (171-180 of 341) with videos related to

Pageof 35
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|July 19, 2011
Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs valsartan by ambulatory blood pressure monitoringDomenic Sica, William B White, Michael A Weber, et al.
Perspectives in Vascular Surgery and Endovascular Therapy|October 25, 2006
Upper extremity arterial combat injury managementMichael A Weber, Charles J Fox, Eric Adams, et al.
Andrology|October 10, 2024
Single-arm study of testosterone gel replacement therapy and ambulatory blood pressure outcomes in men with hypogonadismMichael A Weber, Shamaila Aslam, Mitchell D Efros, et al.
European Heart Journal|February 27, 2004
Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)Uwe Zeymer, Albrecht Vogt, Ralf Zahn, et al.
Diabetologia|July 20, 2014
Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studiesRoland E Schmieder, Rudolph Schutte, Helmut Schumacher, et al.
Hypertension (Dallas, Tex. : 1979)|June 20, 2012
Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertensionWilliam C Cushman, George L Bakris, William B White, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 6, 2006
An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurementsMichael A Weber, William B White, Thomas D Giles, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 27, 2012
Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial studyDomenic Sica, George L Bakris, William B White, et al.
Hypertension (Dallas, Tex. : 1979)|May 8, 2024
Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE TrialMislav Vrsalovic, Sondre Heimark, Camilla L Søraas, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 9, 2009
ASH Position Paper: Dietary approaches to lower blood pressureLawrence J Appel, , Thomas D Giles, et al.
Pageof 35

Showing results (171-180 of 341) with videos related to

Sort By:
Pageof 35
Journal of Clinical Hypertension (Greenwich, Conn.)|July 19, 2011
Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs valsartan by ambulatory blood pressure monitoringDomenic Sica, William B White, Michael A Weber, et al.
Perspectives in Vascular Surgery and Endovascular Therapy|October 25, 2006
Upper extremity arterial combat injury managementMichael A Weber, Charles J Fox, Eric Adams, et al.
Andrology|October 10, 2024
Single-arm study of testosterone gel replacement therapy and ambulatory blood pressure outcomes in men with hypogonadismMichael A Weber, Shamaila Aslam, Mitchell D Efros, et al.
European Heart Journal|February 27, 2004
Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)Uwe Zeymer, Albrecht Vogt, Ralf Zahn, et al.
Diabetologia|July 20, 2014
Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studiesRoland E Schmieder, Rudolph Schutte, Helmut Schumacher, et al.
Hypertension (Dallas, Tex. : 1979)|June 20, 2012
Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertensionWilliam C Cushman, George L Bakris, William B White, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 6, 2006
An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurementsMichael A Weber, William B White, Thomas D Giles, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 27, 2012
Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial studyDomenic Sica, George L Bakris, William B White, et al.
Hypertension (Dallas, Tex. : 1979)|May 8, 2024
Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE TrialMislav Vrsalovic, Sondre Heimark, Camilla L Søraas, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 9, 2009
ASH Position Paper: Dietary approaches to lower blood pressureLawrence J Appel, , Thomas D Giles, et al.
Pageof 35